Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ramucirumab Paclitaxel”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Not applicableNot Yet RecruitingNCT07144995
What this trial is testing

MAIC of Fruquintinib Plus Paclitaxel Versus Ramucirumab Plus Paclitaxel in Advanced G/GEJ Adenocarcinoma

Who this might be right for
Advanced Gastric CancerGastroesophageal Junction AdenocarcinomaFruquintinib+1 more
Sun Yat-sen University 1,143
Testing effectiveness (Phase 2)Study completedNCT02730247
What this trial is testing

Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Liza Villaruz, MD 7
Testing effectiveness (Phase 2)Study completedNCT03762564
What this trial is testing

Study With Paclitaxel +/- Ramucirumab in Patients With Squamous-cell Carcinoma of the Esophagus After Prior Therapy

Who this might be right for
Squamous Cell Carcinoma of the Esophagus
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 21
Large-scale testing (Phase 3)Study completedNCT04499924
What this trial is testing

Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma
Seagen Inc. 17
Testing effectiveness (Phase 2)Study completedNCT00735696
What this trial is testing

Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 41
Not applicableStudy completedNCT06666582
What this trial is testing

Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer

Who this might be right for
Gastric Cancer Stage IVSecond-line TreatmentRamucirumab Paclitaxel
Hellenic Cooperative Oncology Group 185
Not applicableUnknownNCT05301465
What this trial is testing

Predictive Role of Circulating Angiogenic Factors for Second-line Paclitaxel and Ramucirumab.

Who this might be right for
Gastric Cancer Stage IV
University of Pisa 50
Testing effectiveness (Phase 2)UnknownNCT03921671
What this trial is testing

Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT)

Who this might be right for
Thymic CarcinomaThymoma
Claudia Proto 60
Testing effectiveness (Phase 2)UnknownNCT03760822
What this trial is testing

Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients

Who this might be right for
Stomach CancerStomach NeoplasmGastric Cancer+1 more
Federation Francophone de Cancerologie Digestive 112